InnoCare Pharma Ltd. ( (HK:9969) ) has provided an announcement.
InnoCare Pharma Ltd. has announced its upcoming annual general meeting scheduled for June 20, 2025, in Beijing, China. The meeting will address several key resolutions, including the approval of the 2024 financial statements, annual report, work report of the board of directors, and profit distribution plan. Additionally, the company seeks shareholder approval to authorize the directors to allot and issue new shares or securities convertible into shares, with limitations set by the Hong Kong Stock Exchange rules. This announcement could impact the company’s operational flexibility and shareholder value by potentially increasing the share capital.
More about InnoCare Pharma Ltd.
InnoCare Pharma Ltd. is a pharmaceutical company incorporated in the Cayman Islands, focusing on innovative drug development and commercialization. The company is listed on the Hong Kong Stock Exchange, with a market focus on life sciences and healthcare solutions.
YTD Price Performance: 65.69%
Average Trading Volume: 12,796,074
Technical Sentiment Signal: Sell
Current Market Cap: HK$15.17B
See more insights into 9969 stock on TipRanks’ Stock Analysis page.